Ciglitazone
Energy-restricting drug helps destroy cancer cells
April 26, 2010Researchers have designed a new anticancer agent that targets the survival mechanism of cancer cells, according to a report published in the Journal of Biological Chemistry (2010;285(16):9780-9791).
Sign Up for Free e-newsletters
ONA Articles
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- Rituximab Maintenance Improved Long-Term Survival in Elderly With Follicular Lymphoma
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- Integrating Preoperative Oral Care Into Cancer Treatment Plans
- Benefit of Chemotherapy for Breast Cancer Observed With Midrange Gene Assay Score
- Antioxidant Interaction With Cancer Therapy
- Young Survivors of Breast Cancer Report Sexual Quality of Life Declines After Treatment
- Myeloablative Conditioning Effective in AML Secondary to MDS/MPN Prior to Allogeneic HCT
- Insurance Status Influences Overall Survival in Follicular Lymphoma
- American Association for Cancer Research Releases Its 2018 Annual Report
- Acrylamide in Food and Cancer Risk (Fact Sheet)
- Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
- Current Status and Dilemma of Second-line Treatment in Advanced Pancreatic Cancer: Is There a Silver Lining?
- Use of Anti-inflammatory Analgesics Has a Positive Effect on Survival Outcomes in Ovarian Cancer
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |